RxDoctor Payments Data
★ My doctorsLook up a doctor →

Michael Redler, MD

Hand Surgery · Trumbull, CTNPI 1215960067

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Bioventus LLC accounts for 79.3% of it on its own, with 28 other manufacturers making up the rest. Among hand surgery clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$762,559in general payments, 2019–2025

Across 666 payments — averaging $1144.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$605K
  • Medical Device Business Services, Inc.$75K
  • Linvatec Corporation$56K
  • Geistlich Pharma, North America, Inc.$7K
  • Biorez, Inc.$5K
  • Pacira Pharmaceuticals Incorporated$4K
  • plus $10K from 23 others
$3,000in research payments, 2019–2025

Across 6 payments — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$3K

What the payments were for

  • Royalty or licence$1,2140%
  • Consulting fees$221,91729%
  • Speaking & faculty fees$451,92259%
  • Travel & lodging$73,56010%
  • Food & beverage$13,9462%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bioventus LLC458$604,932
Medical Device Business Services, Inc.62$75,318
Linvatec Corporation36$55,845
Geistlich Pharma, North America, Inc.1$7,350
Biorez, Inc.1$5,000
Pacira Pharmaceuticals Incorporated7$4,281
Acelrx Pharmaceuticals, Inc.2$2,014
Johnson & Johnson43$1,685
Depuy Synthes Products, Inc.1$1,260
Buxton Biomedical7$1,214
Arthrex14$1,166
Conmed Corporation2$772
Smith+Nephew6$349
Miach Orthopaedics, Inc.2$299
Anika Therapeutics, Inc.2$221
Vericel Corporation3$171
Pacira Therapeutics, Inc.2$139
Brixton Biosciences, Inc.1$123
Trice Medical, Inc.1$102
Vertex2$58
Endo Pharmaceuticals Inc.4$54
ERMI LLC1$47
Medline Industries LP1$41
Baudax Bio Inc.2$32
Orthofix Medical, Inc.1$27
Innovation Technologies Inc1$16
Endo USA, Inc.1$15
Sanofi-aventis U.S. LLC1$13
Amgen1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$762,559 in reported general payments places this provider in the 95th percentile of 54 hand surgery providers in Connecticut.

See all hand surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024
$70,577
Medicare patients
118
Services billed
1,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam46$91

Paid to pharmacies, not to this prescriber.

Other hand surgery in Trumbull

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →